These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of cytotechnologists' and cytopathologists' ASCUS rates preimplementation and postimplementation of the ThinPrep® imaging system. Selvaggi SM. Diagn Cytopathol; 2015 Feb; 43(2):105-7. PubMed ID: 24962256 [Abstract] [Full Text] [Related]
3. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process. Renshaw AA, DiNisco SA, Minter LJ, Cibas ES. Cancer; 1997 Oct 25; 81(5):272-6. PubMed ID: 9349513 [Abstract] [Full Text] [Related]
4. Utility of the Thin Prep Imaging System® in the detection of squamous intraepithelial abnormalities on retrospective evaluation: can we trust the imager? Barroeta JE, Reilly ME, Steinhoff MM, Lawrence WD. Diagn Cytopathol; 2012 Feb 25; 40(2):124-7. PubMed ID: 22246928 [Abstract] [Full Text] [Related]
5. Is there a role for the thinprep imaging system in reporting anal cytology? Margaret Roberts J, Jin F, Ekman D, Kay Adams M, Lindsay McDonald R, Kathleen Thurloe J, Richards A, Mary Poynten I, Law C, Kincaid Fairley C, John Hillman R, Tabrizi SN, Marie Cornall A, James Templeton D, Marie Garland S, Edwin Grulich A, Farnsworth A. Diagn Cytopathol; 2016 May 25; 44(5):384-8. PubMed ID: 26876374 [Abstract] [Full Text] [Related]
6. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Pitman MB, Cibas ES, Powers CN, Renshaw AA, Frable WJ. Cancer; 2002 Jun 25; 96(3):128-34. PubMed ID: 12115299 [Abstract] [Full Text] [Related]
8. Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practice. Chivukula M, Saad RS, Elishaev E, White S, Mauser N, Dabbs DJ. Cytojournal; 2007 Feb 08; 4():6. PubMed ID: 17288596 [Abstract] [Full Text] [Related]
9. Resolving ASCUS without recourse to HPV testing: manual reprocessing of residual automated liquid-based cytology (ALBC) material using manual liquid-based cytology (MLBC). Maksem JA, Bedrossian CW, Kurtycz D, Sewall S, Shalkham J, Dhanwada V, Lind H, Bibbo M, Weidmann J, Kane B, Shi Fu Y. Diagn Cytopathol; 2005 Dec 08; 33(6):434-40. PubMed ID: 16299747 [Abstract] [Full Text] [Related]
11. Implementation of the ThinPrep imaging system in a high-volume metropolitan laboratory. Miller FS, Nagel LE, Kenny-Moynihan MB. Diagn Cytopathol; 2007 Apr 08; 35(4):213-7. PubMed ID: 17351933 [Abstract] [Full Text] [Related]
12. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial. Renshaw AA, Lezon KM, Wilbur DC. Cancer; 2001 Apr 25; 93(2):106-10. PubMed ID: 11309775 [Abstract] [Full Text] [Related]
13. Use of the ThinPrep Imaging System does not alter the frequency of interpreting Papanicolaou tests as atypical squamous cells of undetermined significance. Thrall MJ, Russell DK, Bonfiglio TA, Hoda RS. Cytojournal; 2008 Apr 24; 5():10. PubMed ID: 18435848 [Abstract] [Full Text] [Related]
14. Automated screening versus manual screening: a comparison of the ThinPrep imaging system and manual screening in a time study. Schledermann D, Hyldebrandt T, Ejersbo D, Hoelund B. Diagn Cytopathol; 2007 Jun 24; 35(6):348-52. PubMed ID: 17497655 [Abstract] [Full Text] [Related]
15. The effectiveness of cytological rescreening in the reduction of false negative/positive Pap reports. Cernescu EC, Anton G, Ruţă S, Cernescu C. Roum Arch Microbiol Immunol; 2013 Jun 24; 72(2):93-104. PubMed ID: 24187808 [Abstract] [Full Text] [Related]
16. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Thrall MJ, Pambuccian SE, Stelow EB, McKeon DM, Miller L, Savik K, Gulbahce HE. Cancer; 2008 Jun 25; 114(3):171-9. PubMed ID: 18454461 [Abstract] [Full Text] [Related]
17. Use of the ThinPrep Imaging System for internal quality control of cervical cytology. Heard T, Chandra A, Culora G, Gupta SS, Herbert A, Morgan M. Cytopathology; 2013 Aug 25; 24(4):246-53. PubMed ID: 22937891 [Abstract] [Full Text] [Related]
18. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Toll AD, Kelly D, Maleki Z. Diagn Cytopathol; 2014 Jul 25; 42(7):576-81. PubMed ID: 24288264 [Abstract] [Full Text] [Related]
19. Evaluation of PAPNET system for rescreening of negative cervical smears. Ashfaq R, Liang Y, Saboorian MH. Diagn Cytopathol; 1995 Jul 25; 13(1):31-6. PubMed ID: 7587873 [Abstract] [Full Text] [Related]
20. BestCyte® primary screening of 500 ThinPrep Pap Test thin-layers: 3 Cytologists' Interobserver diagnostic concordance with predicate manual microscopy relative to Truth Reference diagnoses defining NILM, ASCUS+, LSIL+, and ASCH+ thresholds for specificity, sensitivity, and equivalency grading. Chantziantoniou N. J Pathol Inform; 2023 Jul 25; 14():100182. PubMed ID: 36747889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]